Citizens Financial Group Inc RI lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.5% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,625 shares of the biopharmaceutical company’s stock after selling 327 shares during the quarter. Citizens Financial […]
Magnus Financial Group LLC increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.0% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,516 shares of the biopharmaceutical company’s stock after purchasing an additional 15 shares during the quarter. Magnus Financial […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price boosted by Royal Bank of Canada from $818.00 to $820.00 in a research report report published on Friday morning, Benzinga reports. They currently have a sector perform rating on the biopharmaceutical company’s stock. Other research analysts have also issued research reports about the stock. SVB […]
Intellectus Partners LLC lifted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,877 shares of the biopharmaceutical company’s stock after purchasing an additional 22 shares during the period. […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totalling 1,270,000 shares, an increase of 17.6% from the June 30th total of 1,080,000 shares. Based on an average daily volume of 631,800 shares, […]